Development and Preliminary Validation of a PROS Scale for Chinese Bladder Cancer Patients with Abdominal Stoma

Overview

Journal Sci Rep

Specialty Science

Date 2024 Jan 25

PMID 38273011

Authors

Jingya Lu

Hui Hong

Zhufeng Xiong

Yonghui Zhang

Fanyan Zeng

Zhiqin Xie

Mengjia Yu

Xiaohan Liu

Huiting Li

Daming Xian

Junjie Shen

Affiliations

Soon will be listed here.

Abstract

Bladder cancer is a common malignant tumor, and patients who have undergone radical cystectomy and urinary diversion require a lifelong abdominal stoma. This greatly affects their physiological, psychological, and social well-being. However, there is currently a lack of a self-assessment outcome scale specifically designed for bladder cancer patients with abdominal stomas. Therefore, we developed and validated a self-assessment outcome scale (PROS-BCAS) for Chinese bladder cancer patients with abdominal stomas. The scale was initially developed through literature research and expert consultation, and it comprised four dimensions: physiological, psychological, social, and treatment, with a total of 66 items. After item analysis, 44 items were retained. We collected scale data from 382 patients to examine its validity and reliability. The results showed that the PROS-BCAS scale had good content validity (S-CVI/Ave = 0.992), construct validity (KMO > 0.6), and discriminant validity (correlation coefficient 0.404-0.870). The Cronbach's alpha coefficients (0.801-0.954), test-retest reliability (0.778-0.956), and split-half reliability (0.896-0.977) all demonstrated good internal consistency for each dimension and the overall scale. The study demonstrated that the PROS-BCAS scale is a reliable and valid tool for accurately assessing the health-related quality of life of bladder cancer patients with abdominal stomas, providing reference for developing individualized clinical care plans.

References

Cella D, Stone A . Health-related quality of life measurement in oncology: advances and opportunities. Am Psychol. 2015; 70(2):175-85. DOI: 10.1037/a0037821. View

Grobet-Jeandin E, Pinar U, Parra J, Roupret M, Seisen T . Health-related quality of life after curative treatment for muscle-invasive bladder cancer. Nat Rev Urol. 2023; 20(5):279-293. DOI: 10.1038/s41585-022-00693-z. View

Taneja C, Netsch D, Rolstad B, Inglese G, Eaves D, Oster G . Risk and Economic Burden of Peristomal Skin Complications Following Ostomy Surgery. J Wound Ostomy Continence Nurs. 2019; 46(2):143-149. PMC: 6519780. DOI: 10.1097/WON.0000000000000509. View

Kikuchi E, Horiguchi Y, Nakashima J, Ohigashi T, Oya M, Nakagawa K . Assessment of long-term quality of life using the FACT-BL questionnaire in patients with an ileal conduit, continent reservoir, or orthotopic neobladder. Jpn J Clin Oncol. 2006; 36(11):712-6. DOI: 10.1093/jjco/hyl094. View

Zhang T, Qi X . Enhanced Nursing Care for Improving the Self-Efficacy & Health-Related Quality of Life in Patients with a Urostomy. J Multidiscip Healthc. 2023; 16:297-308. PMC: 9893841. DOI: 10.2147/JMDH.S394515. View

Clements M, Atkinson T, Dalbagni G, Li Y, Vickers A, Herr H . Health-related Quality of Life for Patients Undergoing Radical Cystectomy: Results of a Large Prospective Cohort. Eur Urol. 2021; 81(3):294-304. PMC: 8891075. DOI: 10.1016/j.eururo.2021.09.018. View

Kaufmann T, Rocque G . Pathway to Precision Patient-Reported Outcomes. J Clin Oncol. 2021; 39(34):3770-3772. DOI: 10.1200/JCO.21.02163. View

Patel V, Oh W, Galsky M . Treatment of muscle-invasive and advanced bladder cancer in 2020. CA Cancer J Clin. 2020; 70(5):404-423. DOI: 10.3322/caac.21631. View

Gilbert S, Wood D, Dunn R, Weizer A, Lee C, Montie J . Measuring health-related quality of life outcomes in bladder cancer patients using the Bladder Cancer Index (BCI). Cancer. 2007; 109(9):1756-62. DOI: 10.1002/cncr.22556. View

10.

Wang W, Ding Y, Lu Q, Qi J, Zhang S . The development of a behaviour questionnaire for stoma self-management for persons with bladder cancer and an ileal conduit. J Adv Nurs. 2020; 77(2):1085-1095. DOI: 10.1111/jan.14662. View

11.

Masiero M, Busacchio D, Guiddi P, Arnaboldi P, Musi G, de Cobelli O . Quality of life and psycho-emotional wellbeing in bladder cancer patients and their caregivers: a comparative analysis between urostomy versus ileal orthotopic neobladder. Ecancermedicalscience. 2021; 15:1163. PMC: 7929779. DOI: 10.3332/ecancer.2021.1163. View

12.

Kulkarni G, Hermanns T, Wei Y, Bhindi B, Satkunasivam R, Athanasopoulos P . Propensity Score Analysis of Radical Cystectomy Versus Bladder-Sparing Trimodal Therapy in the Setting of a Multidisciplinary Bladder Cancer Clinic. J Clin Oncol. 2017; 35(20):2299-2305. DOI: 10.1200/JCO.2016.69.2327. View

13.

Chen W . Cancer statistics: updated cancer burden in China. Chin J Cancer Res. 2015; 27(1):1. PMC: 4329178. DOI: 10.3978/j.issn.1000-9604.2015.02.07. View

14.

Belita E, Fisher K, Yost J, Squires J, Ganann R, Dobbins M . Validity, reliability, and acceptability of the Evidence-Informed Decision-Making (EIDM) competence measure. PLoS One. 2022; 17(8):e0272699. PMC: 9355195. DOI: 10.1371/journal.pone.0272699. View

15.

Rotenstein L, Huckman R, Wagle N . Making Patients and Doctors Happier - The Potential of Patient-Reported Outcomes. N Engl J Med. 2017; 377(14):1309-1312. DOI: 10.1056/NEJMp1707537. View

16.

Alanee S, Alvarado-Cabrero I, Murugan P, Kumar R, Nepple K, Paner G . Update of the International Consultation on Urological Diseases on bladder cancer 2018: non-urothelial cancers of the urinary bladder. World J Urol. 2018; 37(1):107-114. DOI: 10.1007/s00345-018-2421-5. View

17.

Sung H, Ferlay J, Siegel R, Laversanne M, Soerjomataram I, Jemal A . Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021; 71(3):209-249. DOI: 10.3322/caac.21660. View

18.

Black N . Patient reported outcome measures could help transform healthcare. BMJ. 2013; 346:f167. DOI: 10.1136/bmj.f167. View

19.

Aaronson N, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez N . The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993; 85(5):365-76. DOI: 10.1093/jnci/85.5.365. View

20.

Taneja C, Netsch D, Rolstad B, Inglese G, Lamerato L, Oster G . Clinical and Economic Burden of Peristomal Skin Complications in Patients With Recent Ostomies. J Wound Ostomy Continence Nurs. 2017; 44(4):350-357. PMC: 5507819. DOI: 10.1097/WON.0000000000000339. View